Interleukin-35 administration counteracts established murine type 1 diabetes – possible involvement of regulatory T cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interleukin-35 administration counteracts established murine type 1 diabetes – possible involvement of regulatory T cells

Published:2015-07-30 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Singh Kailash,Kadesjö Erik,Lindroos Julia,Hjort Marcus,Lundberg Marcus,Espes Daniel,Carlsson Per-Ola,Sandler Stellan,Thorvaldson Lina

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep12633.pdf

Reference58 articles.

1. Atkinson, M. A., Eisenbarth, G. S. & Michels, A. W. Type 1 diabetes. Lancet 383, 69–82 (2014).

2. Diana, J. et al. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med 19, 65–73 (2013).

3. Coppieters, K. T. et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 209, 51–60 (2012).

4. Ehrenstein, M. R. et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200, 277–285 (2004).

5. Bluestone, J. A. & Tang, Q. How do CD4+CD25+ regulatory T cells control autoimmunity? Curr Opi Immunol 17, 638–642 (2005).

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential therapeutic role of IL-35 in pathophysiological processes in type 1 diabetes mellitus;Cytokine;2024-10

2. Regulatory T cell-based therapy in type 1 diabetes: Latest breakthroughs and evidence;International Immunopharmacology;2024-10

3. Prediction model for developing neuropsychiatric systemic lupus erythematosus in lupus patients;Clinical Rheumatology;2024-04-27

4. Assessing the effectiveness of Interleukin-2 therapy in experimental type 1 diabetes;Endocrine;2024-02-29

5. Targeting IL-12 family cytokines: A potential strategy for type 1 and type 2 diabetes mellitus;Biomedicine & Pharmacotherapy;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3